<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04CVBG" lang="spa" raw_text_char_length="3198" raw_text_md5="45250c357d2c60c5ce5ad3ae9b75c10b" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="76" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Un estudio aviva el debate sobre la eficacia del remdesivir para la COVID-19</ORIGINAL_TEXT>
<TOKEN end_char="2" id="token-0-0" morph="none" pos="word" start_char="1">Un</TOKEN>
<TOKEN end_char="10" id="token-0-1" morph="none" pos="word" start_char="4">estudio</TOKEN>
<TOKEN end_char="16" id="token-0-2" morph="none" pos="word" start_char="12">aviva</TOKEN>
<TOKEN end_char="19" id="token-0-3" morph="none" pos="word" start_char="18">el</TOKEN>
<TOKEN end_char="26" id="token-0-4" morph="none" pos="word" start_char="21">debate</TOKEN>
<TOKEN end_char="32" id="token-0-5" morph="none" pos="word" start_char="28">sobre</TOKEN>
<TOKEN end_char="35" id="token-0-6" morph="none" pos="word" start_char="34">la</TOKEN>
<TOKEN end_char="44" id="token-0-7" morph="none" pos="word" start_char="37">eficacia</TOKEN>
<TOKEN end_char="48" id="token-0-8" morph="none" pos="word" start_char="46">del</TOKEN>
<TOKEN end_char="59" id="token-0-9" morph="none" pos="word" start_char="50">remdesivir</TOKEN>
<TOKEN end_char="64" id="token-0-10" morph="none" pos="word" start_char="61">para</TOKEN>
<TOKEN end_char="67" id="token-0-11" morph="none" pos="word" start_char="66">la</TOKEN>
<TOKEN end_char="76" id="token-0-12" morph="none" pos="unknown" start_char="69">COVID-19</TOKEN>
<TRANSLATED_TEXT>A study fuels debate on the efficacy of remdesivir for COVID-19</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="265" id="segment-1" start_char="80">
<ORIGINAL_TEXT>FOTO DE ARCHIVO: Una ampolla de medicamento remdesivir fotografiada durante una rueda de prensa en el Hospital Universitario Eppendorf (UKE) en Hamburgo, Alemania, el 8 de abril de 2020.</ORIGINAL_TEXT>
<TOKEN end_char="83" id="token-1-0" morph="none" pos="word" start_char="80">FOTO</TOKEN>
<TOKEN end_char="86" id="token-1-1" morph="none" pos="word" start_char="85">DE</TOKEN>
<TOKEN end_char="94" id="token-1-2" morph="none" pos="word" start_char="88">ARCHIVO</TOKEN>
<TOKEN end_char="95" id="token-1-3" morph="none" pos="punct" start_char="95">:</TOKEN>
<TOKEN end_char="99" id="token-1-4" morph="none" pos="word" start_char="97">Una</TOKEN>
<TOKEN end_char="107" id="token-1-5" morph="none" pos="word" start_char="101">ampolla</TOKEN>
<TOKEN end_char="110" id="token-1-6" morph="none" pos="word" start_char="109">de</TOKEN>
<TOKEN end_char="122" id="token-1-7" morph="none" pos="word" start_char="112">medicamento</TOKEN>
<TOKEN end_char="133" id="token-1-8" morph="none" pos="word" start_char="124">remdesivir</TOKEN>
<TOKEN end_char="146" id="token-1-9" morph="none" pos="word" start_char="135">fotografiada</TOKEN>
<TOKEN end_char="154" id="token-1-10" morph="none" pos="word" start_char="148">durante</TOKEN>
<TOKEN end_char="158" id="token-1-11" morph="none" pos="word" start_char="156">una</TOKEN>
<TOKEN end_char="164" id="token-1-12" morph="none" pos="word" start_char="160">rueda</TOKEN>
<TOKEN end_char="167" id="token-1-13" morph="none" pos="word" start_char="166">de</TOKEN>
<TOKEN end_char="174" id="token-1-14" morph="none" pos="word" start_char="169">prensa</TOKEN>
<TOKEN end_char="177" id="token-1-15" morph="none" pos="word" start_char="176">en</TOKEN>
<TOKEN end_char="180" id="token-1-16" morph="none" pos="word" start_char="179">el</TOKEN>
<TOKEN end_char="189" id="token-1-17" morph="none" pos="word" start_char="182">Hospital</TOKEN>
<TOKEN end_char="203" id="token-1-18" morph="none" pos="word" start_char="191">Universitario</TOKEN>
<TOKEN end_char="213" id="token-1-19" morph="none" pos="word" start_char="205">Eppendorf</TOKEN>
<TOKEN end_char="215" id="token-1-20" morph="none" pos="punct" start_char="215">(</TOKEN>
<TOKEN end_char="218" id="token-1-21" morph="none" pos="word" start_char="216">UKE</TOKEN>
<TOKEN end_char="219" id="token-1-22" morph="none" pos="punct" start_char="219">)</TOKEN>
<TOKEN end_char="222" id="token-1-23" morph="none" pos="word" start_char="221">en</TOKEN>
<TOKEN end_char="231" id="token-1-24" morph="none" pos="word" start_char="224">Hamburgo</TOKEN>
<TOKEN end_char="232" id="token-1-25" morph="none" pos="punct" start_char="232">,</TOKEN>
<TOKEN end_char="241" id="token-1-26" morph="none" pos="word" start_char="234">Alemania</TOKEN>
<TOKEN end_char="242" id="token-1-27" morph="none" pos="punct" start_char="242">,</TOKEN>
<TOKEN end_char="245" id="token-1-28" morph="none" pos="word" start_char="244">el</TOKEN>
<TOKEN end_char="247" id="token-1-29" morph="none" pos="word" start_char="247">8</TOKEN>
<TOKEN end_char="250" id="token-1-30" morph="none" pos="word" start_char="249">de</TOKEN>
<TOKEN end_char="256" id="token-1-31" morph="none" pos="word" start_char="252">abril</TOKEN>
<TOKEN end_char="259" id="token-1-32" morph="none" pos="word" start_char="258">de</TOKEN>
<TOKEN end_char="264" id="token-1-33" morph="none" pos="word" start_char="261">2020</TOKEN>
<TOKEN end_char="265" id="token-1-34" morph="none" pos="punct" start_char="265">.</TOKEN>
<TRANSLATED_TEXT>ARCHIVE PHOTO: A bottle of remdesivir medicine photographed during a press conference at Eppendorf University Hospital (UKE) in Hamburg, Germany, on April 8, 2020.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="296" id="segment-2" start_char="267">
<ORIGINAL_TEXT>Ulrich Perrey/Pool vía REUTERS</ORIGINAL_TEXT>
<TOKEN end_char="272" id="token-2-0" morph="none" pos="word" start_char="267">Ulrich</TOKEN>
<TOKEN end_char="284" id="token-2-1" morph="none" pos="unknown" start_char="274">Perrey/Pool</TOKEN>
<TOKEN end_char="288" id="token-2-2" morph="none" pos="word" start_char="286">vía</TOKEN>
<TOKEN end_char="296" id="token-2-3" morph="none" pos="word" start_char="290">REUTERS</TOKEN>
</SEG>
<SEG end_char="670" id="segment-3" start_char="300">
<ORIGINAL_TEXT>LONDRES, 14 dic (Reuters) - Un estudio realizado con un solo paciente llevado a cabo por científicos británicos ha encontrado que el medicamento antiviral remdesivir de Gilead podría ser altamente efectivo contra la COVID-19, lo que ha planteado interrogantes sobre estudios previos que concluyeron que no tenía ningún impacto en las tasas de mortalidad de la enfermedad.</ORIGINAL_TEXT>
<TOKEN end_char="306" id="token-3-0" morph="none" pos="word" start_char="300">LONDRES</TOKEN>
<TOKEN end_char="307" id="token-3-1" morph="none" pos="punct" start_char="307">,</TOKEN>
<TOKEN end_char="310" id="token-3-2" morph="none" pos="word" start_char="309">14</TOKEN>
<TOKEN end_char="314" id="token-3-3" morph="none" pos="word" start_char="312">dic</TOKEN>
<TOKEN end_char="316" id="token-3-4" morph="none" pos="punct" start_char="316">(</TOKEN>
<TOKEN end_char="323" id="token-3-5" morph="none" pos="word" start_char="317">Reuters</TOKEN>
<TOKEN end_char="324" id="token-3-6" morph="none" pos="punct" start_char="324">)</TOKEN>
<TOKEN end_char="326" id="token-3-7" morph="none" pos="punct" start_char="326">-</TOKEN>
<TOKEN end_char="329" id="token-3-8" morph="none" pos="word" start_char="328">Un</TOKEN>
<TOKEN end_char="337" id="token-3-9" morph="none" pos="word" start_char="331">estudio</TOKEN>
<TOKEN end_char="347" id="token-3-10" morph="none" pos="word" start_char="339">realizado</TOKEN>
<TOKEN end_char="351" id="token-3-11" morph="none" pos="word" start_char="349">con</TOKEN>
<TOKEN end_char="354" id="token-3-12" morph="none" pos="word" start_char="353">un</TOKEN>
<TOKEN end_char="359" id="token-3-13" morph="none" pos="word" start_char="356">solo</TOKEN>
<TOKEN end_char="368" id="token-3-14" morph="none" pos="word" start_char="361">paciente</TOKEN>
<TOKEN end_char="376" id="token-3-15" morph="none" pos="word" start_char="370">llevado</TOKEN>
<TOKEN end_char="378" id="token-3-16" morph="none" pos="word" start_char="378">a</TOKEN>
<TOKEN end_char="383" id="token-3-17" morph="none" pos="word" start_char="380">cabo</TOKEN>
<TOKEN end_char="387" id="token-3-18" morph="none" pos="word" start_char="385">por</TOKEN>
<TOKEN end_char="399" id="token-3-19" morph="none" pos="word" start_char="389">científicos</TOKEN>
<TOKEN end_char="410" id="token-3-20" morph="none" pos="word" start_char="401">británicos</TOKEN>
<TOKEN end_char="413" id="token-3-21" morph="none" pos="word" start_char="412">ha</TOKEN>
<TOKEN end_char="424" id="token-3-22" morph="none" pos="word" start_char="415">encontrado</TOKEN>
<TOKEN end_char="428" id="token-3-23" morph="none" pos="word" start_char="426">que</TOKEN>
<TOKEN end_char="431" id="token-3-24" morph="none" pos="word" start_char="430">el</TOKEN>
<TOKEN end_char="443" id="token-3-25" morph="none" pos="word" start_char="433">medicamento</TOKEN>
<TOKEN end_char="453" id="token-3-26" morph="none" pos="word" start_char="445">antiviral</TOKEN>
<TOKEN end_char="464" id="token-3-27" morph="none" pos="word" start_char="455">remdesivir</TOKEN>
<TOKEN end_char="467" id="token-3-28" morph="none" pos="word" start_char="466">de</TOKEN>
<TOKEN end_char="474" id="token-3-29" morph="none" pos="word" start_char="469">Gilead</TOKEN>
<TOKEN end_char="481" id="token-3-30" morph="none" pos="word" start_char="476">podría</TOKEN>
<TOKEN end_char="485" id="token-3-31" morph="none" pos="word" start_char="483">ser</TOKEN>
<TOKEN end_char="495" id="token-3-32" morph="none" pos="word" start_char="487">altamente</TOKEN>
<TOKEN end_char="504" id="token-3-33" morph="none" pos="word" start_char="497">efectivo</TOKEN>
<TOKEN end_char="511" id="token-3-34" morph="none" pos="word" start_char="506">contra</TOKEN>
<TOKEN end_char="514" id="token-3-35" morph="none" pos="word" start_char="513">la</TOKEN>
<TOKEN end_char="523" id="token-3-36" morph="none" pos="unknown" start_char="516">COVID-19</TOKEN>
<TOKEN end_char="524" id="token-3-37" morph="none" pos="punct" start_char="524">,</TOKEN>
<TOKEN end_char="527" id="token-3-38" morph="none" pos="word" start_char="526">lo</TOKEN>
<TOKEN end_char="531" id="token-3-39" morph="none" pos="word" start_char="529">que</TOKEN>
<TOKEN end_char="534" id="token-3-40" morph="none" pos="word" start_char="533">ha</TOKEN>
<TOKEN end_char="544" id="token-3-41" morph="none" pos="word" start_char="536">planteado</TOKEN>
<TOKEN end_char="558" id="token-3-42" morph="none" pos="word" start_char="546">interrogantes</TOKEN>
<TOKEN end_char="564" id="token-3-43" morph="none" pos="word" start_char="560">sobre</TOKEN>
<TOKEN end_char="573" id="token-3-44" morph="none" pos="word" start_char="566">estudios</TOKEN>
<TOKEN end_char="581" id="token-3-45" morph="none" pos="word" start_char="575">previos</TOKEN>
<TOKEN end_char="585" id="token-3-46" morph="none" pos="word" start_char="583">que</TOKEN>
<TOKEN end_char="597" id="token-3-47" morph="none" pos="word" start_char="587">concluyeron</TOKEN>
<TOKEN end_char="601" id="token-3-48" morph="none" pos="word" start_char="599">que</TOKEN>
<TOKEN end_char="604" id="token-3-49" morph="none" pos="word" start_char="603">no</TOKEN>
<TOKEN end_char="610" id="token-3-50" morph="none" pos="word" start_char="606">tenía</TOKEN>
<TOKEN end_char="617" id="token-3-51" morph="none" pos="word" start_char="612">ningún</TOKEN>
<TOKEN end_char="625" id="token-3-52" morph="none" pos="word" start_char="619">impacto</TOKEN>
<TOKEN end_char="628" id="token-3-53" morph="none" pos="word" start_char="627">en</TOKEN>
<TOKEN end_char="632" id="token-3-54" morph="none" pos="word" start_char="630">las</TOKEN>
<TOKEN end_char="638" id="token-3-55" morph="none" pos="word" start_char="634">tasas</TOKEN>
<TOKEN end_char="641" id="token-3-56" morph="none" pos="word" start_char="640">de</TOKEN>
<TOKEN end_char="652" id="token-3-57" morph="none" pos="word" start_char="643">mortalidad</TOKEN>
<TOKEN end_char="655" id="token-3-58" morph="none" pos="word" start_char="654">de</TOKEN>
<TOKEN end_char="658" id="token-3-59" morph="none" pos="word" start_char="657">la</TOKEN>
<TOKEN end_char="669" id="token-3-60" morph="none" pos="word" start_char="660">enfermedad</TOKEN>
<TOKEN end_char="670" id="token-3-61" morph="none" pos="punct" start_char="670">.</TOKEN>
<TRANSLATED_TEXT>LONDON, December 14 (Reuters) - A single-patient study conducted by British scientists has found that the antiviral drug remdesivir from Gilead could be highly effective against COVID-19, raising questions about previous studies that concluded that it had no impact on the disease's mortality rates.,,,,,,,,,,,,,,,</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="969" id="segment-4" start_char="673">
<ORIGINAL_TEXT>El estudio, publicado en la revista Nature Communications, describe cómo los médicos que dieron este medicamento a un paciente que sufría tanto de COVID-19 como de otro raro desorden inmunológico vieron una mejoría significativa en los síntomas del paciente y finalmente la desaparición del virus.</ORIGINAL_TEXT>
<TOKEN end_char="674" id="token-4-0" morph="none" pos="word" start_char="673">El</TOKEN>
<TOKEN end_char="682" id="token-4-1" morph="none" pos="word" start_char="676">estudio</TOKEN>
<TOKEN end_char="683" id="token-4-2" morph="none" pos="punct" start_char="683">,</TOKEN>
<TOKEN end_char="693" id="token-4-3" morph="none" pos="word" start_char="685">publicado</TOKEN>
<TOKEN end_char="696" id="token-4-4" morph="none" pos="word" start_char="695">en</TOKEN>
<TOKEN end_char="699" id="token-4-5" morph="none" pos="word" start_char="698">la</TOKEN>
<TOKEN end_char="707" id="token-4-6" morph="none" pos="word" start_char="701">revista</TOKEN>
<TOKEN end_char="714" id="token-4-7" morph="none" pos="word" start_char="709">Nature</TOKEN>
<TOKEN end_char="729" id="token-4-8" morph="none" pos="word" start_char="716">Communications</TOKEN>
<TOKEN end_char="730" id="token-4-9" morph="none" pos="punct" start_char="730">,</TOKEN>
<TOKEN end_char="739" id="token-4-10" morph="none" pos="word" start_char="732">describe</TOKEN>
<TOKEN end_char="744" id="token-4-11" morph="none" pos="word" start_char="741">cómo</TOKEN>
<TOKEN end_char="748" id="token-4-12" morph="none" pos="word" start_char="746">los</TOKEN>
<TOKEN end_char="756" id="token-4-13" morph="none" pos="word" start_char="750">médicos</TOKEN>
<TOKEN end_char="760" id="token-4-14" morph="none" pos="word" start_char="758">que</TOKEN>
<TOKEN end_char="767" id="token-4-15" morph="none" pos="word" start_char="762">dieron</TOKEN>
<TOKEN end_char="772" id="token-4-16" morph="none" pos="word" start_char="769">este</TOKEN>
<TOKEN end_char="784" id="token-4-17" morph="none" pos="word" start_char="774">medicamento</TOKEN>
<TOKEN end_char="786" id="token-4-18" morph="none" pos="word" start_char="786">a</TOKEN>
<TOKEN end_char="789" id="token-4-19" morph="none" pos="word" start_char="788">un</TOKEN>
<TOKEN end_char="798" id="token-4-20" morph="none" pos="word" start_char="791">paciente</TOKEN>
<TOKEN end_char="802" id="token-4-21" morph="none" pos="word" start_char="800">que</TOKEN>
<TOKEN end_char="809" id="token-4-22" morph="none" pos="word" start_char="804">sufría</TOKEN>
<TOKEN end_char="815" id="token-4-23" morph="none" pos="word" start_char="811">tanto</TOKEN>
<TOKEN end_char="818" id="token-4-24" morph="none" pos="word" start_char="817">de</TOKEN>
<TOKEN end_char="827" id="token-4-25" morph="none" pos="unknown" start_char="820">COVID-19</TOKEN>
<TOKEN end_char="832" id="token-4-26" morph="none" pos="word" start_char="829">como</TOKEN>
<TOKEN end_char="835" id="token-4-27" morph="none" pos="word" start_char="834">de</TOKEN>
<TOKEN end_char="840" id="token-4-28" morph="none" pos="word" start_char="837">otro</TOKEN>
<TOKEN end_char="845" id="token-4-29" morph="none" pos="word" start_char="842">raro</TOKEN>
<TOKEN end_char="854" id="token-4-30" morph="none" pos="word" start_char="847">desorden</TOKEN>
<TOKEN end_char="867" id="token-4-31" morph="none" pos="word" start_char="856">inmunológico</TOKEN>
<TOKEN end_char="874" id="token-4-32" morph="none" pos="word" start_char="869">vieron</TOKEN>
<TOKEN end_char="878" id="token-4-33" morph="none" pos="word" start_char="876">una</TOKEN>
<TOKEN end_char="886" id="token-4-34" morph="none" pos="word" start_char="880">mejoría</TOKEN>
<TOKEN end_char="900" id="token-4-35" morph="none" pos="word" start_char="888">significativa</TOKEN>
<TOKEN end_char="903" id="token-4-36" morph="none" pos="word" start_char="902">en</TOKEN>
<TOKEN end_char="907" id="token-4-37" morph="none" pos="word" start_char="905">los</TOKEN>
<TOKEN end_char="916" id="token-4-38" morph="none" pos="word" start_char="909">síntomas</TOKEN>
<TOKEN end_char="920" id="token-4-39" morph="none" pos="word" start_char="918">del</TOKEN>
<TOKEN end_char="929" id="token-4-40" morph="none" pos="word" start_char="922">paciente</TOKEN>
<TOKEN end_char="931" id="token-4-41" morph="none" pos="word" start_char="931">y</TOKEN>
<TOKEN end_char="942" id="token-4-42" morph="none" pos="word" start_char="933">finalmente</TOKEN>
<TOKEN end_char="945" id="token-4-43" morph="none" pos="word" start_char="944">la</TOKEN>
<TOKEN end_char="958" id="token-4-44" morph="none" pos="word" start_char="947">desaparición</TOKEN>
<TOKEN end_char="962" id="token-4-45" morph="none" pos="word" start_char="960">del</TOKEN>
<TOKEN end_char="968" id="token-4-46" morph="none" pos="word" start_char="964">virus</TOKEN>
<TOKEN end_char="969" id="token-4-47" morph="none" pos="punct" start_char="969">.</TOKEN>
<TRANSLATED_TEXT>The study, published in the journal Nature Communications, describes how doctors who gave this drug to a patient suffering from both COVID-19 and another rare immune disorder saw a significant improvement in the patient's symptoms and eventually the virus's disappearance.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1269" id="segment-5" start_char="972">
<ORIGINAL_TEXT>"El inusual estado de nuestro paciente nos dio una rara visión de la eficacia del remdesivir como tratamiento para la infección por coronavirus", dijo Nicholas Matheson, quien codirigió el estudio en el Instituto de Inmunología Terapéutica y Enfermedades Infecciosas de la Universidad de Cambridge.</ORIGINAL_TEXT>
<TOKEN end_char="972" id="token-5-0" morph="none" pos="punct" start_char="972">"</TOKEN>
<TOKEN end_char="974" id="token-5-1" morph="none" pos="word" start_char="973">El</TOKEN>
<TOKEN end_char="982" id="token-5-2" morph="none" pos="word" start_char="976">inusual</TOKEN>
<TOKEN end_char="989" id="token-5-3" morph="none" pos="word" start_char="984">estado</TOKEN>
<TOKEN end_char="992" id="token-5-4" morph="none" pos="word" start_char="991">de</TOKEN>
<TOKEN end_char="1000" id="token-5-5" morph="none" pos="word" start_char="994">nuestro</TOKEN>
<TOKEN end_char="1009" id="token-5-6" morph="none" pos="word" start_char="1002">paciente</TOKEN>
<TOKEN end_char="1013" id="token-5-7" morph="none" pos="word" start_char="1011">nos</TOKEN>
<TOKEN end_char="1017" id="token-5-8" morph="none" pos="word" start_char="1015">dio</TOKEN>
<TOKEN end_char="1021" id="token-5-9" morph="none" pos="word" start_char="1019">una</TOKEN>
<TOKEN end_char="1026" id="token-5-10" morph="none" pos="word" start_char="1023">rara</TOKEN>
<TOKEN end_char="1033" id="token-5-11" morph="none" pos="word" start_char="1028">visión</TOKEN>
<TOKEN end_char="1036" id="token-5-12" morph="none" pos="word" start_char="1035">de</TOKEN>
<TOKEN end_char="1039" id="token-5-13" morph="none" pos="word" start_char="1038">la</TOKEN>
<TOKEN end_char="1048" id="token-5-14" morph="none" pos="word" start_char="1041">eficacia</TOKEN>
<TOKEN end_char="1052" id="token-5-15" morph="none" pos="word" start_char="1050">del</TOKEN>
<TOKEN end_char="1063" id="token-5-16" morph="none" pos="word" start_char="1054">remdesivir</TOKEN>
<TOKEN end_char="1068" id="token-5-17" morph="none" pos="word" start_char="1065">como</TOKEN>
<TOKEN end_char="1080" id="token-5-18" morph="none" pos="word" start_char="1070">tratamiento</TOKEN>
<TOKEN end_char="1085" id="token-5-19" morph="none" pos="word" start_char="1082">para</TOKEN>
<TOKEN end_char="1088" id="token-5-20" morph="none" pos="word" start_char="1087">la</TOKEN>
<TOKEN end_char="1098" id="token-5-21" morph="none" pos="word" start_char="1090">infección</TOKEN>
<TOKEN end_char="1102" id="token-5-22" morph="none" pos="word" start_char="1100">por</TOKEN>
<TOKEN end_char="1114" id="token-5-23" morph="none" pos="word" start_char="1104">coronavirus</TOKEN>
<TOKEN end_char="1116" id="token-5-24" morph="none" pos="punct" start_char="1115">",</TOKEN>
<TOKEN end_char="1121" id="token-5-25" morph="none" pos="word" start_char="1118">dijo</TOKEN>
<TOKEN end_char="1130" id="token-5-26" morph="none" pos="word" start_char="1123">Nicholas</TOKEN>
<TOKEN end_char="1139" id="token-5-27" morph="none" pos="word" start_char="1132">Matheson</TOKEN>
<TOKEN end_char="1140" id="token-5-28" morph="none" pos="punct" start_char="1140">,</TOKEN>
<TOKEN end_char="1146" id="token-5-29" morph="none" pos="word" start_char="1142">quien</TOKEN>
<TOKEN end_char="1156" id="token-5-30" morph="none" pos="word" start_char="1148">codirigió</TOKEN>
<TOKEN end_char="1159" id="token-5-31" morph="none" pos="word" start_char="1158">el</TOKEN>
<TOKEN end_char="1167" id="token-5-32" morph="none" pos="word" start_char="1161">estudio</TOKEN>
<TOKEN end_char="1170" id="token-5-33" morph="none" pos="word" start_char="1169">en</TOKEN>
<TOKEN end_char="1173" id="token-5-34" morph="none" pos="word" start_char="1172">el</TOKEN>
<TOKEN end_char="1183" id="token-5-35" morph="none" pos="word" start_char="1175">Instituto</TOKEN>
<TOKEN end_char="1186" id="token-5-36" morph="none" pos="word" start_char="1185">de</TOKEN>
<TOKEN end_char="1198" id="token-5-37" morph="none" pos="word" start_char="1188">Inmunología</TOKEN>
<TOKEN end_char="1210" id="token-5-38" morph="none" pos="word" start_char="1200">Terapéutica</TOKEN>
<TOKEN end_char="1212" id="token-5-39" morph="none" pos="word" start_char="1212">y</TOKEN>
<TOKEN end_char="1225" id="token-5-40" morph="none" pos="word" start_char="1214">Enfermedades</TOKEN>
<TOKEN end_char="1237" id="token-5-41" morph="none" pos="word" start_char="1227">Infecciosas</TOKEN>
<TOKEN end_char="1240" id="token-5-42" morph="none" pos="word" start_char="1239">de</TOKEN>
<TOKEN end_char="1243" id="token-5-43" morph="none" pos="word" start_char="1242">la</TOKEN>
<TOKEN end_char="1255" id="token-5-44" morph="none" pos="word" start_char="1245">Universidad</TOKEN>
<TOKEN end_char="1258" id="token-5-45" morph="none" pos="word" start_char="1257">de</TOKEN>
<TOKEN end_char="1268" id="token-5-46" morph="none" pos="word" start_char="1260">Cambridge</TOKEN>
<TOKEN end_char="1269" id="token-5-47" morph="none" pos="punct" start_char="1269">.</TOKEN>
<TRANSLATED_TEXT>"The unusual state of our patient gave us a rare view of remdesivir's efficacy as a treatment for coronavirus infection," said Nicholas Matheson, who co-led the study at the Institute of Therapeutic Immunology and Infectious Diseases at the University of Cambridge.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1404" id="segment-6" start_char="1272">
<ORIGINAL_TEXT>"La radical respuesta al medicamento (...) sugiere que puede ser un tratamiento altamente efectivo, al menos para algunos pacientes".</ORIGINAL_TEXT>
<TOKEN end_char="1272" id="token-6-0" morph="none" pos="punct" start_char="1272">"</TOKEN>
<TOKEN end_char="1274" id="token-6-1" morph="none" pos="word" start_char="1273">La</TOKEN>
<TOKEN end_char="1282" id="token-6-2" morph="none" pos="word" start_char="1276">radical</TOKEN>
<TOKEN end_char="1292" id="token-6-3" morph="none" pos="word" start_char="1284">respuesta</TOKEN>
<TOKEN end_char="1295" id="token-6-4" morph="none" pos="word" start_char="1294">al</TOKEN>
<TOKEN end_char="1307" id="token-6-5" morph="none" pos="word" start_char="1297">medicamento</TOKEN>
<TOKEN end_char="1313" id="token-6-6" morph="none" pos="punct" start_char="1309">(...)</TOKEN>
<TOKEN end_char="1321" id="token-6-7" morph="none" pos="word" start_char="1315">sugiere</TOKEN>
<TOKEN end_char="1325" id="token-6-8" morph="none" pos="word" start_char="1323">que</TOKEN>
<TOKEN end_char="1331" id="token-6-9" morph="none" pos="word" start_char="1327">puede</TOKEN>
<TOKEN end_char="1335" id="token-6-10" morph="none" pos="word" start_char="1333">ser</TOKEN>
<TOKEN end_char="1338" id="token-6-11" morph="none" pos="word" start_char="1337">un</TOKEN>
<TOKEN end_char="1350" id="token-6-12" morph="none" pos="word" start_char="1340">tratamiento</TOKEN>
<TOKEN end_char="1360" id="token-6-13" morph="none" pos="word" start_char="1352">altamente</TOKEN>
<TOKEN end_char="1369" id="token-6-14" morph="none" pos="word" start_char="1362">efectivo</TOKEN>
<TOKEN end_char="1370" id="token-6-15" morph="none" pos="punct" start_char="1370">,</TOKEN>
<TOKEN end_char="1373" id="token-6-16" morph="none" pos="word" start_char="1372">al</TOKEN>
<TOKEN end_char="1379" id="token-6-17" morph="none" pos="word" start_char="1375">menos</TOKEN>
<TOKEN end_char="1384" id="token-6-18" morph="none" pos="word" start_char="1381">para</TOKEN>
<TOKEN end_char="1392" id="token-6-19" morph="none" pos="word" start_char="1386">algunos</TOKEN>
<TOKEN end_char="1402" id="token-6-20" morph="none" pos="word" start_char="1394">pacientes</TOKEN>
<TOKEN end_char="1404" id="token-6-21" morph="none" pos="punct" start_char="1403">".</TOKEN>
<TRANSLATED_TEXT>The radical response to the drug (...) suggests that it can be a highly effective treatment, at least for some patients.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1647" id="segment-7" start_char="1406">
<ORIGINAL_TEXT>Desde los inicios de la pandemia del coronavirus, los científicos esperaban que el remdesivir, que fue originalmente desarrollado para tratar la hepatitis C y posteriormente probado contra el Ébola, pudiera resultar eficaz contra la COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="1410" id="token-7-0" morph="none" pos="word" start_char="1406">Desde</TOKEN>
<TOKEN end_char="1414" id="token-7-1" morph="none" pos="word" start_char="1412">los</TOKEN>
<TOKEN end_char="1422" id="token-7-2" morph="none" pos="word" start_char="1416">inicios</TOKEN>
<TOKEN end_char="1425" id="token-7-3" morph="none" pos="word" start_char="1424">de</TOKEN>
<TOKEN end_char="1428" id="token-7-4" morph="none" pos="word" start_char="1427">la</TOKEN>
<TOKEN end_char="1437" id="token-7-5" morph="none" pos="word" start_char="1430">pandemia</TOKEN>
<TOKEN end_char="1441" id="token-7-6" morph="none" pos="word" start_char="1439">del</TOKEN>
<TOKEN end_char="1453" id="token-7-7" morph="none" pos="word" start_char="1443">coronavirus</TOKEN>
<TOKEN end_char="1454" id="token-7-8" morph="none" pos="punct" start_char="1454">,</TOKEN>
<TOKEN end_char="1458" id="token-7-9" morph="none" pos="word" start_char="1456">los</TOKEN>
<TOKEN end_char="1470" id="token-7-10" morph="none" pos="word" start_char="1460">científicos</TOKEN>
<TOKEN end_char="1480" id="token-7-11" morph="none" pos="word" start_char="1472">esperaban</TOKEN>
<TOKEN end_char="1484" id="token-7-12" morph="none" pos="word" start_char="1482">que</TOKEN>
<TOKEN end_char="1487" id="token-7-13" morph="none" pos="word" start_char="1486">el</TOKEN>
<TOKEN end_char="1498" id="token-7-14" morph="none" pos="word" start_char="1489">remdesivir</TOKEN>
<TOKEN end_char="1499" id="token-7-15" morph="none" pos="punct" start_char="1499">,</TOKEN>
<TOKEN end_char="1503" id="token-7-16" morph="none" pos="word" start_char="1501">que</TOKEN>
<TOKEN end_char="1507" id="token-7-17" morph="none" pos="word" start_char="1505">fue</TOKEN>
<TOKEN end_char="1521" id="token-7-18" morph="none" pos="word" start_char="1509">originalmente</TOKEN>
<TOKEN end_char="1534" id="token-7-19" morph="none" pos="word" start_char="1523">desarrollado</TOKEN>
<TOKEN end_char="1539" id="token-7-20" morph="none" pos="word" start_char="1536">para</TOKEN>
<TOKEN end_char="1546" id="token-7-21" morph="none" pos="word" start_char="1541">tratar</TOKEN>
<TOKEN end_char="1549" id="token-7-22" morph="none" pos="word" start_char="1548">la</TOKEN>
<TOKEN end_char="1559" id="token-7-23" morph="none" pos="word" start_char="1551">hepatitis</TOKEN>
<TOKEN end_char="1561" id="token-7-24" morph="none" pos="word" start_char="1561">C</TOKEN>
<TOKEN end_char="1563" id="token-7-25" morph="none" pos="word" start_char="1563">y</TOKEN>
<TOKEN end_char="1578" id="token-7-26" morph="none" pos="word" start_char="1565">posteriormente</TOKEN>
<TOKEN end_char="1586" id="token-7-27" morph="none" pos="word" start_char="1580">probado</TOKEN>
<TOKEN end_char="1593" id="token-7-28" morph="none" pos="word" start_char="1588">contra</TOKEN>
<TOKEN end_char="1596" id="token-7-29" morph="none" pos="word" start_char="1595">el</TOKEN>
<TOKEN end_char="1602" id="token-7-30" morph="none" pos="word" start_char="1598">Ébola</TOKEN>
<TOKEN end_char="1603" id="token-7-31" morph="none" pos="punct" start_char="1603">,</TOKEN>
<TOKEN end_char="1611" id="token-7-32" morph="none" pos="word" start_char="1605">pudiera</TOKEN>
<TOKEN end_char="1620" id="token-7-33" morph="none" pos="word" start_char="1613">resultar</TOKEN>
<TOKEN end_char="1627" id="token-7-34" morph="none" pos="word" start_char="1622">eficaz</TOKEN>
<TOKEN end_char="1634" id="token-7-35" morph="none" pos="word" start_char="1629">contra</TOKEN>
<TOKEN end_char="1637" id="token-7-36" morph="none" pos="word" start_char="1636">la</TOKEN>
<TOKEN end_char="1646" id="token-7-37" morph="none" pos="unknown" start_char="1639">COVID-19</TOKEN>
<TOKEN end_char="1647" id="token-7-38" morph="none" pos="punct" start_char="1647">.</TOKEN>
<TRANSLATED_TEXT>From the beginning of the coronavirus pandemic, scientists hoped that remdesivir, which was originally developed to treat hepatitis C and subsequently tested against Ebola, could be effective against COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="1850" id="segment-8" start_char="1649">
<ORIGINAL_TEXT>Su eficacia, no obstante, ha sido muy discutida desde que un gran ensayo dirigido por la Organización Mundial de la Salud revelara en octubre que no mejoraba las tasas de supervivencia ante la COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="1650" id="token-8-0" morph="none" pos="word" start_char="1649">Su</TOKEN>
<TOKEN end_char="1659" id="token-8-1" morph="none" pos="word" start_char="1652">eficacia</TOKEN>
<TOKEN end_char="1660" id="token-8-2" morph="none" pos="punct" start_char="1660">,</TOKEN>
<TOKEN end_char="1663" id="token-8-3" morph="none" pos="word" start_char="1662">no</TOKEN>
<TOKEN end_char="1672" id="token-8-4" morph="none" pos="word" start_char="1665">obstante</TOKEN>
<TOKEN end_char="1673" id="token-8-5" morph="none" pos="punct" start_char="1673">,</TOKEN>
<TOKEN end_char="1676" id="token-8-6" morph="none" pos="word" start_char="1675">ha</TOKEN>
<TOKEN end_char="1681" id="token-8-7" morph="none" pos="word" start_char="1678">sido</TOKEN>
<TOKEN end_char="1685" id="token-8-8" morph="none" pos="word" start_char="1683">muy</TOKEN>
<TOKEN end_char="1695" id="token-8-9" morph="none" pos="word" start_char="1687">discutida</TOKEN>
<TOKEN end_char="1701" id="token-8-10" morph="none" pos="word" start_char="1697">desde</TOKEN>
<TOKEN end_char="1705" id="token-8-11" morph="none" pos="word" start_char="1703">que</TOKEN>
<TOKEN end_char="1708" id="token-8-12" morph="none" pos="word" start_char="1707">un</TOKEN>
<TOKEN end_char="1713" id="token-8-13" morph="none" pos="word" start_char="1710">gran</TOKEN>
<TOKEN end_char="1720" id="token-8-14" morph="none" pos="word" start_char="1715">ensayo</TOKEN>
<TOKEN end_char="1729" id="token-8-15" morph="none" pos="word" start_char="1722">dirigido</TOKEN>
<TOKEN end_char="1733" id="token-8-16" morph="none" pos="word" start_char="1731">por</TOKEN>
<TOKEN end_char="1736" id="token-8-17" morph="none" pos="word" start_char="1735">la</TOKEN>
<TOKEN end_char="1749" id="token-8-18" morph="none" pos="word" start_char="1738">Organización</TOKEN>
<TOKEN end_char="1757" id="token-8-19" morph="none" pos="word" start_char="1751">Mundial</TOKEN>
<TOKEN end_char="1760" id="token-8-20" morph="none" pos="word" start_char="1759">de</TOKEN>
<TOKEN end_char="1763" id="token-8-21" morph="none" pos="word" start_char="1762">la</TOKEN>
<TOKEN end_char="1769" id="token-8-22" morph="none" pos="word" start_char="1765">Salud</TOKEN>
<TOKEN end_char="1778" id="token-8-23" morph="none" pos="word" start_char="1771">revelara</TOKEN>
<TOKEN end_char="1781" id="token-8-24" morph="none" pos="word" start_char="1780">en</TOKEN>
<TOKEN end_char="1789" id="token-8-25" morph="none" pos="word" start_char="1783">octubre</TOKEN>
<TOKEN end_char="1793" id="token-8-26" morph="none" pos="word" start_char="1791">que</TOKEN>
<TOKEN end_char="1796" id="token-8-27" morph="none" pos="word" start_char="1795">no</TOKEN>
<TOKEN end_char="1805" id="token-8-28" morph="none" pos="word" start_char="1798">mejoraba</TOKEN>
<TOKEN end_char="1809" id="token-8-29" morph="none" pos="word" start_char="1807">las</TOKEN>
<TOKEN end_char="1815" id="token-8-30" morph="none" pos="word" start_char="1811">tasas</TOKEN>
<TOKEN end_char="1818" id="token-8-31" morph="none" pos="word" start_char="1817">de</TOKEN>
<TOKEN end_char="1832" id="token-8-32" morph="none" pos="word" start_char="1820">supervivencia</TOKEN>
<TOKEN end_char="1837" id="token-8-33" morph="none" pos="word" start_char="1834">ante</TOKEN>
<TOKEN end_char="1840" id="token-8-34" morph="none" pos="word" start_char="1839">la</TOKEN>
<TOKEN end_char="1849" id="token-8-35" morph="none" pos="unknown" start_char="1842">COVID-19</TOKEN>
<TOKEN end_char="1850" id="token-8-36" morph="none" pos="punct" start_char="1850">.</TOKEN>
<TRANSLATED_TEXT>Its efficacy, however, has been much debated since a major trial led by the World Health Organization revealed in October that it did not improve survival rates for COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2141" id="segment-9" start_char="1853">
<ORIGINAL_TEXT>"Ha habido diferentes estudios que apoyan o cuestionan la eficacia del remdesivir, pero algunos de los realizados durante la primera ola de infecciones pueden no ser óptimos para evaluar sus propiedades antivirales", dijo James Thaventhiran, de Cambridge, quien también trabajó en el caso.</ORIGINAL_TEXT>
<TOKEN end_char="1853" id="token-9-0" morph="none" pos="punct" start_char="1853">"</TOKEN>
<TOKEN end_char="1855" id="token-9-1" morph="none" pos="word" start_char="1854">Ha</TOKEN>
<TOKEN end_char="1862" id="token-9-2" morph="none" pos="word" start_char="1857">habido</TOKEN>
<TOKEN end_char="1873" id="token-9-3" morph="none" pos="word" start_char="1864">diferentes</TOKEN>
<TOKEN end_char="1882" id="token-9-4" morph="none" pos="word" start_char="1875">estudios</TOKEN>
<TOKEN end_char="1886" id="token-9-5" morph="none" pos="word" start_char="1884">que</TOKEN>
<TOKEN end_char="1893" id="token-9-6" morph="none" pos="word" start_char="1888">apoyan</TOKEN>
<TOKEN end_char="1895" id="token-9-7" morph="none" pos="word" start_char="1895">o</TOKEN>
<TOKEN end_char="1906" id="token-9-8" morph="none" pos="word" start_char="1897">cuestionan</TOKEN>
<TOKEN end_char="1909" id="token-9-9" morph="none" pos="word" start_char="1908">la</TOKEN>
<TOKEN end_char="1918" id="token-9-10" morph="none" pos="word" start_char="1911">eficacia</TOKEN>
<TOKEN end_char="1922" id="token-9-11" morph="none" pos="word" start_char="1920">del</TOKEN>
<TOKEN end_char="1933" id="token-9-12" morph="none" pos="word" start_char="1924">remdesivir</TOKEN>
<TOKEN end_char="1934" id="token-9-13" morph="none" pos="punct" start_char="1934">,</TOKEN>
<TOKEN end_char="1939" id="token-9-14" morph="none" pos="word" start_char="1936">pero</TOKEN>
<TOKEN end_char="1947" id="token-9-15" morph="none" pos="word" start_char="1941">algunos</TOKEN>
<TOKEN end_char="1950" id="token-9-16" morph="none" pos="word" start_char="1949">de</TOKEN>
<TOKEN end_char="1954" id="token-9-17" morph="none" pos="word" start_char="1952">los</TOKEN>
<TOKEN end_char="1965" id="token-9-18" morph="none" pos="word" start_char="1956">realizados</TOKEN>
<TOKEN end_char="1973" id="token-9-19" morph="none" pos="word" start_char="1967">durante</TOKEN>
<TOKEN end_char="1976" id="token-9-20" morph="none" pos="word" start_char="1975">la</TOKEN>
<TOKEN end_char="1984" id="token-9-21" morph="none" pos="word" start_char="1978">primera</TOKEN>
<TOKEN end_char="1988" id="token-9-22" morph="none" pos="word" start_char="1986">ola</TOKEN>
<TOKEN end_char="1991" id="token-9-23" morph="none" pos="word" start_char="1990">de</TOKEN>
<TOKEN end_char="2003" id="token-9-24" morph="none" pos="word" start_char="1993">infecciones</TOKEN>
<TOKEN end_char="2010" id="token-9-25" morph="none" pos="word" start_char="2005">pueden</TOKEN>
<TOKEN end_char="2013" id="token-9-26" morph="none" pos="word" start_char="2012">no</TOKEN>
<TOKEN end_char="2017" id="token-9-27" morph="none" pos="word" start_char="2015">ser</TOKEN>
<TOKEN end_char="2025" id="token-9-28" morph="none" pos="word" start_char="2019">óptimos</TOKEN>
<TOKEN end_char="2030" id="token-9-29" morph="none" pos="word" start_char="2027">para</TOKEN>
<TOKEN end_char="2038" id="token-9-30" morph="none" pos="word" start_char="2032">evaluar</TOKEN>
<TOKEN end_char="2042" id="token-9-31" morph="none" pos="word" start_char="2040">sus</TOKEN>
<TOKEN end_char="2054" id="token-9-32" morph="none" pos="word" start_char="2044">propiedades</TOKEN>
<TOKEN end_char="2066" id="token-9-33" morph="none" pos="word" start_char="2056">antivirales</TOKEN>
<TOKEN end_char="2068" id="token-9-34" morph="none" pos="punct" start_char="2067">",</TOKEN>
<TOKEN end_char="2073" id="token-9-35" morph="none" pos="word" start_char="2070">dijo</TOKEN>
<TOKEN end_char="2079" id="token-9-36" morph="none" pos="word" start_char="2075">James</TOKEN>
<TOKEN end_char="2092" id="token-9-37" morph="none" pos="word" start_char="2081">Thaventhiran</TOKEN>
<TOKEN end_char="2093" id="token-9-38" morph="none" pos="punct" start_char="2093">,</TOKEN>
<TOKEN end_char="2096" id="token-9-39" morph="none" pos="word" start_char="2095">de</TOKEN>
<TOKEN end_char="2106" id="token-9-40" morph="none" pos="word" start_char="2098">Cambridge</TOKEN>
<TOKEN end_char="2107" id="token-9-41" morph="none" pos="punct" start_char="2107">,</TOKEN>
<TOKEN end_char="2113" id="token-9-42" morph="none" pos="word" start_char="2109">quien</TOKEN>
<TOKEN end_char="2121" id="token-9-43" morph="none" pos="word" start_char="2115">también</TOKEN>
<TOKEN end_char="2129" id="token-9-44" morph="none" pos="word" start_char="2123">trabajó</TOKEN>
<TOKEN end_char="2132" id="token-9-45" morph="none" pos="word" start_char="2131">en</TOKEN>
<TOKEN end_char="2135" id="token-9-46" morph="none" pos="word" start_char="2134">el</TOKEN>
<TOKEN end_char="2140" id="token-9-47" morph="none" pos="word" start_char="2137">caso</TOKEN>
<TOKEN end_char="2141" id="token-9-48" morph="none" pos="punct" start_char="2141">.</TOKEN>
<TRANSLATED_TEXT>"There have been different studies that support or question the efficacy of remdesivir, but some of the studies conducted during the first wave of infections may not be optimal for evaluating its antiviral properties," said James Thavenhiran, of Cambridge, who also worked on the case.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2377" id="segment-10" start_char="2144">
<ORIGINAL_TEXT>La investigación se centró un hombre de 31 años que se enfermó gravemente de COVID-19 y que también tenía una rara condición genética llamada XLA que afecta la capacidad del cuerpo para producir anticuerpos para combatir la infección.</ORIGINAL_TEXT>
<TOKEN end_char="2145" id="token-10-0" morph="none" pos="word" start_char="2144">La</TOKEN>
<TOKEN end_char="2159" id="token-10-1" morph="none" pos="word" start_char="2147">investigación</TOKEN>
<TOKEN end_char="2162" id="token-10-2" morph="none" pos="word" start_char="2161">se</TOKEN>
<TOKEN end_char="2169" id="token-10-3" morph="none" pos="word" start_char="2164">centró</TOKEN>
<TOKEN end_char="2172" id="token-10-4" morph="none" pos="word" start_char="2171">un</TOKEN>
<TOKEN end_char="2179" id="token-10-5" morph="none" pos="word" start_char="2174">hombre</TOKEN>
<TOKEN end_char="2182" id="token-10-6" morph="none" pos="word" start_char="2181">de</TOKEN>
<TOKEN end_char="2185" id="token-10-7" morph="none" pos="word" start_char="2184">31</TOKEN>
<TOKEN end_char="2190" id="token-10-8" morph="none" pos="word" start_char="2187">años</TOKEN>
<TOKEN end_char="2194" id="token-10-9" morph="none" pos="word" start_char="2192">que</TOKEN>
<TOKEN end_char="2197" id="token-10-10" morph="none" pos="word" start_char="2196">se</TOKEN>
<TOKEN end_char="2205" id="token-10-11" morph="none" pos="word" start_char="2199">enfermó</TOKEN>
<TOKEN end_char="2216" id="token-10-12" morph="none" pos="word" start_char="2207">gravemente</TOKEN>
<TOKEN end_char="2219" id="token-10-13" morph="none" pos="word" start_char="2218">de</TOKEN>
<TOKEN end_char="2228" id="token-10-14" morph="none" pos="unknown" start_char="2221">COVID-19</TOKEN>
<TOKEN end_char="2230" id="token-10-15" morph="none" pos="word" start_char="2230">y</TOKEN>
<TOKEN end_char="2234" id="token-10-16" morph="none" pos="word" start_char="2232">que</TOKEN>
<TOKEN end_char="2242" id="token-10-17" morph="none" pos="word" start_char="2236">también</TOKEN>
<TOKEN end_char="2248" id="token-10-18" morph="none" pos="word" start_char="2244">tenía</TOKEN>
<TOKEN end_char="2252" id="token-10-19" morph="none" pos="word" start_char="2250">una</TOKEN>
<TOKEN end_char="2257" id="token-10-20" morph="none" pos="word" start_char="2254">rara</TOKEN>
<TOKEN end_char="2267" id="token-10-21" morph="none" pos="word" start_char="2259">condición</TOKEN>
<TOKEN end_char="2276" id="token-10-22" morph="none" pos="word" start_char="2269">genética</TOKEN>
<TOKEN end_char="2284" id="token-10-23" morph="none" pos="word" start_char="2278">llamada</TOKEN>
<TOKEN end_char="2288" id="token-10-24" morph="none" pos="word" start_char="2286">XLA</TOKEN>
<TOKEN end_char="2292" id="token-10-25" morph="none" pos="word" start_char="2290">que</TOKEN>
<TOKEN end_char="2299" id="token-10-26" morph="none" pos="word" start_char="2294">afecta</TOKEN>
<TOKEN end_char="2302" id="token-10-27" morph="none" pos="word" start_char="2301">la</TOKEN>
<TOKEN end_char="2312" id="token-10-28" morph="none" pos="word" start_char="2304">capacidad</TOKEN>
<TOKEN end_char="2316" id="token-10-29" morph="none" pos="word" start_char="2314">del</TOKEN>
<TOKEN end_char="2323" id="token-10-30" morph="none" pos="word" start_char="2318">cuerpo</TOKEN>
<TOKEN end_char="2328" id="token-10-31" morph="none" pos="word" start_char="2325">para</TOKEN>
<TOKEN end_char="2337" id="token-10-32" morph="none" pos="word" start_char="2330">producir</TOKEN>
<TOKEN end_char="2349" id="token-10-33" morph="none" pos="word" start_char="2339">anticuerpos</TOKEN>
<TOKEN end_char="2354" id="token-10-34" morph="none" pos="word" start_char="2351">para</TOKEN>
<TOKEN end_char="2363" id="token-10-35" morph="none" pos="word" start_char="2356">combatir</TOKEN>
<TOKEN end_char="2366" id="token-10-36" morph="none" pos="word" start_char="2365">la</TOKEN>
<TOKEN end_char="2376" id="token-10-37" morph="none" pos="word" start_char="2368">infección</TOKEN>
<TOKEN end_char="2377" id="token-10-38" morph="none" pos="punct" start_char="2377">.</TOKEN>
<TRANSLATED_TEXT>The research focused on a 31-year-old man who became seriously ill with COVID-19 and who also had a rare genetic condition called XLA that affects the body's ability to produce antibodies to fight infection.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2629" id="segment-11" start_char="2380">
<ORIGINAL_TEXT>Durante un período de más de dos meses, el hombre fue tratado primero con hidroxicloroquina y azitromicina, que tuvieron poco efecto, y posteriormente se le administraron dos dosis separadas de tratamiento con remdesivir, según indicaron los médicos.</ORIGINAL_TEXT>
<TOKEN end_char="2386" id="token-11-0" morph="none" pos="word" start_char="2380">Durante</TOKEN>
<TOKEN end_char="2389" id="token-11-1" morph="none" pos="word" start_char="2388">un</TOKEN>
<TOKEN end_char="2397" id="token-11-2" morph="none" pos="word" start_char="2391">período</TOKEN>
<TOKEN end_char="2400" id="token-11-3" morph="none" pos="word" start_char="2399">de</TOKEN>
<TOKEN end_char="2404" id="token-11-4" morph="none" pos="word" start_char="2402">más</TOKEN>
<TOKEN end_char="2407" id="token-11-5" morph="none" pos="word" start_char="2406">de</TOKEN>
<TOKEN end_char="2411" id="token-11-6" morph="none" pos="word" start_char="2409">dos</TOKEN>
<TOKEN end_char="2417" id="token-11-7" morph="none" pos="word" start_char="2413">meses</TOKEN>
<TOKEN end_char="2418" id="token-11-8" morph="none" pos="punct" start_char="2418">,</TOKEN>
<TOKEN end_char="2421" id="token-11-9" morph="none" pos="word" start_char="2420">el</TOKEN>
<TOKEN end_char="2428" id="token-11-10" morph="none" pos="word" start_char="2423">hombre</TOKEN>
<TOKEN end_char="2432" id="token-11-11" morph="none" pos="word" start_char="2430">fue</TOKEN>
<TOKEN end_char="2440" id="token-11-12" morph="none" pos="word" start_char="2434">tratado</TOKEN>
<TOKEN end_char="2448" id="token-11-13" morph="none" pos="word" start_char="2442">primero</TOKEN>
<TOKEN end_char="2452" id="token-11-14" morph="none" pos="word" start_char="2450">con</TOKEN>
<TOKEN end_char="2470" id="token-11-15" morph="none" pos="word" start_char="2454">hidroxicloroquina</TOKEN>
<TOKEN end_char="2472" id="token-11-16" morph="none" pos="word" start_char="2472">y</TOKEN>
<TOKEN end_char="2485" id="token-11-17" morph="none" pos="word" start_char="2474">azitromicina</TOKEN>
<TOKEN end_char="2486" id="token-11-18" morph="none" pos="punct" start_char="2486">,</TOKEN>
<TOKEN end_char="2490" id="token-11-19" morph="none" pos="word" start_char="2488">que</TOKEN>
<TOKEN end_char="2499" id="token-11-20" morph="none" pos="word" start_char="2492">tuvieron</TOKEN>
<TOKEN end_char="2504" id="token-11-21" morph="none" pos="word" start_char="2501">poco</TOKEN>
<TOKEN end_char="2511" id="token-11-22" morph="none" pos="word" start_char="2506">efecto</TOKEN>
<TOKEN end_char="2512" id="token-11-23" morph="none" pos="punct" start_char="2512">,</TOKEN>
<TOKEN end_char="2514" id="token-11-24" morph="none" pos="word" start_char="2514">y</TOKEN>
<TOKEN end_char="2529" id="token-11-25" morph="none" pos="word" start_char="2516">posteriormente</TOKEN>
<TOKEN end_char="2532" id="token-11-26" morph="none" pos="word" start_char="2531">se</TOKEN>
<TOKEN end_char="2535" id="token-11-27" morph="none" pos="word" start_char="2534">le</TOKEN>
<TOKEN end_char="2549" id="token-11-28" morph="none" pos="word" start_char="2537">administraron</TOKEN>
<TOKEN end_char="2553" id="token-11-29" morph="none" pos="word" start_char="2551">dos</TOKEN>
<TOKEN end_char="2559" id="token-11-30" morph="none" pos="word" start_char="2555">dosis</TOKEN>
<TOKEN end_char="2569" id="token-11-31" morph="none" pos="word" start_char="2561">separadas</TOKEN>
<TOKEN end_char="2572" id="token-11-32" morph="none" pos="word" start_char="2571">de</TOKEN>
<TOKEN end_char="2584" id="token-11-33" morph="none" pos="word" start_char="2574">tratamiento</TOKEN>
<TOKEN end_char="2588" id="token-11-34" morph="none" pos="word" start_char="2586">con</TOKEN>
<TOKEN end_char="2599" id="token-11-35" morph="none" pos="word" start_char="2590">remdesivir</TOKEN>
<TOKEN end_char="2600" id="token-11-36" morph="none" pos="punct" start_char="2600">,</TOKEN>
<TOKEN end_char="2606" id="token-11-37" morph="none" pos="word" start_char="2602">según</TOKEN>
<TOKEN end_char="2616" id="token-11-38" morph="none" pos="word" start_char="2608">indicaron</TOKEN>
<TOKEN end_char="2620" id="token-11-39" morph="none" pos="word" start_char="2618">los</TOKEN>
<TOKEN end_char="2628" id="token-11-40" morph="none" pos="word" start_char="2622">médicos</TOKEN>
<TOKEN end_char="2629" id="token-11-41" morph="none" pos="punct" start_char="2629">.</TOKEN>
<TRANSLATED_TEXT>For a period of more than two months, the man was first treated with hydroxychloroquine and azithromycin, which had little effect, and was subsequently given two separate doses of remdesivir treatment, according to doctors.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2741" id="segment-12" start_char="2632">
<ORIGINAL_TEXT>Los niveles de virus del paciente cayeron y sus síntomas mejoraron durante su primera ciclo con el remdesivir.</ORIGINAL_TEXT>
<TOKEN end_char="2634" id="token-12-0" morph="none" pos="word" start_char="2632">Los</TOKEN>
<TOKEN end_char="2642" id="token-12-1" morph="none" pos="word" start_char="2636">niveles</TOKEN>
<TOKEN end_char="2645" id="token-12-2" morph="none" pos="word" start_char="2644">de</TOKEN>
<TOKEN end_char="2651" id="token-12-3" morph="none" pos="word" start_char="2647">virus</TOKEN>
<TOKEN end_char="2655" id="token-12-4" morph="none" pos="word" start_char="2653">del</TOKEN>
<TOKEN end_char="2664" id="token-12-5" morph="none" pos="word" start_char="2657">paciente</TOKEN>
<TOKEN end_char="2672" id="token-12-6" morph="none" pos="word" start_char="2666">cayeron</TOKEN>
<TOKEN end_char="2674" id="token-12-7" morph="none" pos="word" start_char="2674">y</TOKEN>
<TOKEN end_char="2678" id="token-12-8" morph="none" pos="word" start_char="2676">sus</TOKEN>
<TOKEN end_char="2687" id="token-12-9" morph="none" pos="word" start_char="2680">síntomas</TOKEN>
<TOKEN end_char="2697" id="token-12-10" morph="none" pos="word" start_char="2689">mejoraron</TOKEN>
<TOKEN end_char="2705" id="token-12-11" morph="none" pos="word" start_char="2699">durante</TOKEN>
<TOKEN end_char="2708" id="token-12-12" morph="none" pos="word" start_char="2707">su</TOKEN>
<TOKEN end_char="2716" id="token-12-13" morph="none" pos="word" start_char="2710">primera</TOKEN>
<TOKEN end_char="2722" id="token-12-14" morph="none" pos="word" start_char="2718">ciclo</TOKEN>
<TOKEN end_char="2726" id="token-12-15" morph="none" pos="word" start_char="2724">con</TOKEN>
<TOKEN end_char="2729" id="token-12-16" morph="none" pos="word" start_char="2728">el</TOKEN>
<TOKEN end_char="2740" id="token-12-17" morph="none" pos="word" start_char="2731">remdesivir</TOKEN>
<TOKEN end_char="2741" id="token-12-18" morph="none" pos="punct" start_char="2741">.</TOKEN>
<TRANSLATED_TEXT>The patient's virus levels fell and her symptoms improved during her first cycle with remdesivir.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="2954" id="segment-13" start_char="2743">
<ORIGINAL_TEXT>Y aunque los niveles del virus y los síntomas aumentaron de nuevo después del primer tratamiento con este medicamento, el segundo tratamiento fue aún más eficaz, y para el día 64, ya no dio positivo por COVID-19.</ORIGINAL_TEXT>
<TOKEN end_char="2743" id="token-13-0" morph="none" pos="word" start_char="2743">Y</TOKEN>
<TOKEN end_char="2750" id="token-13-1" morph="none" pos="word" start_char="2745">aunque</TOKEN>
<TOKEN end_char="2754" id="token-13-2" morph="none" pos="word" start_char="2752">los</TOKEN>
<TOKEN end_char="2762" id="token-13-3" morph="none" pos="word" start_char="2756">niveles</TOKEN>
<TOKEN end_char="2766" id="token-13-4" morph="none" pos="word" start_char="2764">del</TOKEN>
<TOKEN end_char="2772" id="token-13-5" morph="none" pos="word" start_char="2768">virus</TOKEN>
<TOKEN end_char="2774" id="token-13-6" morph="none" pos="word" start_char="2774">y</TOKEN>
<TOKEN end_char="2778" id="token-13-7" morph="none" pos="word" start_char="2776">los</TOKEN>
<TOKEN end_char="2787" id="token-13-8" morph="none" pos="word" start_char="2780">síntomas</TOKEN>
<TOKEN end_char="2798" id="token-13-9" morph="none" pos="word" start_char="2789">aumentaron</TOKEN>
<TOKEN end_char="2801" id="token-13-10" morph="none" pos="word" start_char="2800">de</TOKEN>
<TOKEN end_char="2807" id="token-13-11" morph="none" pos="word" start_char="2803">nuevo</TOKEN>
<TOKEN end_char="2815" id="token-13-12" morph="none" pos="word" start_char="2809">después</TOKEN>
<TOKEN end_char="2819" id="token-13-13" morph="none" pos="word" start_char="2817">del</TOKEN>
<TOKEN end_char="2826" id="token-13-14" morph="none" pos="word" start_char="2821">primer</TOKEN>
<TOKEN end_char="2838" id="token-13-15" morph="none" pos="word" start_char="2828">tratamiento</TOKEN>
<TOKEN end_char="2842" id="token-13-16" morph="none" pos="word" start_char="2840">con</TOKEN>
<TOKEN end_char="2847" id="token-13-17" morph="none" pos="word" start_char="2844">este</TOKEN>
<TOKEN end_char="2859" id="token-13-18" morph="none" pos="word" start_char="2849">medicamento</TOKEN>
<TOKEN end_char="2860" id="token-13-19" morph="none" pos="punct" start_char="2860">,</TOKEN>
<TOKEN end_char="2863" id="token-13-20" morph="none" pos="word" start_char="2862">el</TOKEN>
<TOKEN end_char="2871" id="token-13-21" morph="none" pos="word" start_char="2865">segundo</TOKEN>
<TOKEN end_char="2883" id="token-13-22" morph="none" pos="word" start_char="2873">tratamiento</TOKEN>
<TOKEN end_char="2887" id="token-13-23" morph="none" pos="word" start_char="2885">fue</TOKEN>
<TOKEN end_char="2891" id="token-13-24" morph="none" pos="word" start_char="2889">aún</TOKEN>
<TOKEN end_char="2895" id="token-13-25" morph="none" pos="word" start_char="2893">más</TOKEN>
<TOKEN end_char="2902" id="token-13-26" morph="none" pos="word" start_char="2897">eficaz</TOKEN>
<TOKEN end_char="2903" id="token-13-27" morph="none" pos="punct" start_char="2903">,</TOKEN>
<TOKEN end_char="2905" id="token-13-28" morph="none" pos="word" start_char="2905">y</TOKEN>
<TOKEN end_char="2910" id="token-13-29" morph="none" pos="word" start_char="2907">para</TOKEN>
<TOKEN end_char="2913" id="token-13-30" morph="none" pos="word" start_char="2912">el</TOKEN>
<TOKEN end_char="2917" id="token-13-31" morph="none" pos="word" start_char="2915">día</TOKEN>
<TOKEN end_char="2920" id="token-13-32" morph="none" pos="word" start_char="2919">64</TOKEN>
<TOKEN end_char="2921" id="token-13-33" morph="none" pos="punct" start_char="2921">,</TOKEN>
<TOKEN end_char="2924" id="token-13-34" morph="none" pos="word" start_char="2923">ya</TOKEN>
<TOKEN end_char="2927" id="token-13-35" morph="none" pos="word" start_char="2926">no</TOKEN>
<TOKEN end_char="2931" id="token-13-36" morph="none" pos="word" start_char="2929">dio</TOKEN>
<TOKEN end_char="2940" id="token-13-37" morph="none" pos="word" start_char="2933">positivo</TOKEN>
<TOKEN end_char="2944" id="token-13-38" morph="none" pos="word" start_char="2942">por</TOKEN>
<TOKEN end_char="2953" id="token-13-39" morph="none" pos="unknown" start_char="2946">COVID-19</TOKEN>
<TOKEN end_char="2954" id="token-13-40" morph="none" pos="punct" start_char="2954">.</TOKEN>
<TRANSLATED_TEXT>And although the virus levels and symptoms increased again after the first treatment with this drug, the second treatment was even more effective, and by day 64, it no longer tested positive for COVID-19.</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
<SEG end_char="3194" id="segment-14" start_char="2957">
<ORIGINAL_TEXT>"Todo esto sugiere que los tratamientos deberán ser adaptados a cada paciente, dependiendo de su condición subyacente", dijo Matthew Buckland, un médico del departamento de inmunología clínica de Barts en Londres que trabajó con Matheson.</ORIGINAL_TEXT>
<TOKEN end_char="2957" id="token-14-0" morph="none" pos="punct" start_char="2957">"</TOKEN>
<TOKEN end_char="2961" id="token-14-1" morph="none" pos="word" start_char="2958">Todo</TOKEN>
<TOKEN end_char="2966" id="token-14-2" morph="none" pos="word" start_char="2963">esto</TOKEN>
<TOKEN end_char="2974" id="token-14-3" morph="none" pos="word" start_char="2968">sugiere</TOKEN>
<TOKEN end_char="2978" id="token-14-4" morph="none" pos="word" start_char="2976">que</TOKEN>
<TOKEN end_char="2982" id="token-14-5" morph="none" pos="word" start_char="2980">los</TOKEN>
<TOKEN end_char="2995" id="token-14-6" morph="none" pos="word" start_char="2984">tratamientos</TOKEN>
<TOKEN end_char="3003" id="token-14-7" morph="none" pos="word" start_char="2997">deberán</TOKEN>
<TOKEN end_char="3007" id="token-14-8" morph="none" pos="word" start_char="3005">ser</TOKEN>
<TOKEN end_char="3017" id="token-14-9" morph="none" pos="word" start_char="3009">adaptados</TOKEN>
<TOKEN end_char="3019" id="token-14-10" morph="none" pos="word" start_char="3019">a</TOKEN>
<TOKEN end_char="3024" id="token-14-11" morph="none" pos="word" start_char="3021">cada</TOKEN>
<TOKEN end_char="3033" id="token-14-12" morph="none" pos="word" start_char="3026">paciente</TOKEN>
<TOKEN end_char="3034" id="token-14-13" morph="none" pos="punct" start_char="3034">,</TOKEN>
<TOKEN end_char="3046" id="token-14-14" morph="none" pos="word" start_char="3036">dependiendo</TOKEN>
<TOKEN end_char="3049" id="token-14-15" morph="none" pos="word" start_char="3048">de</TOKEN>
<TOKEN end_char="3052" id="token-14-16" morph="none" pos="word" start_char="3051">su</TOKEN>
<TOKEN end_char="3062" id="token-14-17" morph="none" pos="word" start_char="3054">condición</TOKEN>
<TOKEN end_char="3073" id="token-14-18" morph="none" pos="word" start_char="3064">subyacente</TOKEN>
<TOKEN end_char="3075" id="token-14-19" morph="none" pos="punct" start_char="3074">",</TOKEN>
<TOKEN end_char="3080" id="token-14-20" morph="none" pos="word" start_char="3077">dijo</TOKEN>
<TOKEN end_char="3088" id="token-14-21" morph="none" pos="word" start_char="3082">Matthew</TOKEN>
<TOKEN end_char="3097" id="token-14-22" morph="none" pos="word" start_char="3090">Buckland</TOKEN>
<TOKEN end_char="3098" id="token-14-23" morph="none" pos="punct" start_char="3098">,</TOKEN>
<TOKEN end_char="3101" id="token-14-24" morph="none" pos="word" start_char="3100">un</TOKEN>
<TOKEN end_char="3108" id="token-14-25" morph="none" pos="word" start_char="3103">médico</TOKEN>
<TOKEN end_char="3112" id="token-14-26" morph="none" pos="word" start_char="3110">del</TOKEN>
<TOKEN end_char="3125" id="token-14-27" morph="none" pos="word" start_char="3114">departamento</TOKEN>
<TOKEN end_char="3128" id="token-14-28" morph="none" pos="word" start_char="3127">de</TOKEN>
<TOKEN end_char="3140" id="token-14-29" morph="none" pos="word" start_char="3130">inmunología</TOKEN>
<TOKEN end_char="3148" id="token-14-30" morph="none" pos="word" start_char="3142">clínica</TOKEN>
<TOKEN end_char="3151" id="token-14-31" morph="none" pos="word" start_char="3150">de</TOKEN>
<TOKEN end_char="3157" id="token-14-32" morph="none" pos="word" start_char="3153">Barts</TOKEN>
<TOKEN end_char="3160" id="token-14-33" morph="none" pos="word" start_char="3159">en</TOKEN>
<TOKEN end_char="3168" id="token-14-34" morph="none" pos="word" start_char="3162">Londres</TOKEN>
<TOKEN end_char="3172" id="token-14-35" morph="none" pos="word" start_char="3170">que</TOKEN>
<TOKEN end_char="3180" id="token-14-36" morph="none" pos="word" start_char="3174">trabajó</TOKEN>
<TOKEN end_char="3184" id="token-14-37" morph="none" pos="word" start_char="3182">con</TOKEN>
<TOKEN end_char="3193" id="token-14-38" morph="none" pos="word" start_char="3186">Matheson</TOKEN>
<TOKEN end_char="3194" id="token-14-39" morph="none" pos="punct" start_char="3194">.</TOKEN>
<TRANSLATED_TEXT>"All of this suggests that treatments should be tailored to each patient, depending on their underlying condition," said Matthew Buckland, a physician in Barts' clinical immunology department in London who worked with Matheson..............</TRANSLATED_TEXT><DETECTED_LANGUAGE>es</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>